{"schema_version":"secwatch.filing_event.v1","accession":"0001438133-24-000118","form_type":"8-K","ticker":"TNDM","cik":"0001438133","company_name":"TANDEM DIABETES CARE INC","filed_at":"2024-05-23T23:59:59+00:00","discovered_at":"2026-05-14T18:03:18.428477+00:00","generated_at":"2026-06-01T09:08:29.891084+00:00","sec_items":["5.02","5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"high","headline":"Tandem Diabetes stockholders approve 3M-share increases to ESPP and LTIP at annual meeting","bullets":["Stockholders elected all 9 director nominees; highest vote count for John Sheridan (50.3M for).","Approved amendment to 2013 ESPP to increase authorized shares by 3,000,000; 50.4M for, 117,501 against.","Approved amendment to 2023 LTIP to increase authorized shares by 3,000,000; 47.6M for, 3.0M against.","Advisory say-on-pay approved: 47.9M for, 2.3M against, 299,108 abstain.","Ratified Ernst & Young as independent auditor for FY 2024: 53.2M for, 1.4M against."],"urls":{"canonical":"https://secwatch.observer/filing/0001438133-24-000118","json":"https://secwatch.observer/filing/0001438133-24-000118.json","markdown":"https://secwatch.observer/filing/0001438133-24-000118.md","text":"https://secwatch.observer/filing/0001438133-24-000118.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1438133/000143813324000118/0001438133-24-000118-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1438133/000143813324000118/tndm-20240522.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T09:08:29.891084+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}